Centenial Surgical Suture Ltd vs Choksi Laboratories Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Centenial Surgical Suture Ltd is ₹ 67.95 as of 23 Oct 15:30 . The P/E Ratio of Centenial Surgical Suture Ltd changed from 24.1 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Choksi Laboratories Ltd changed from 84.7 on March 2022 to 36.7 on March 2026 . This represents a CAGR of -15.40% over 5 years The Market Cap of Centenial Surgical Suture Ltd changed from ₹ 15.6 crore on March 2021 to ₹ 27.83 crore on March 2026 . This represents a CAGR of 10.13% over 6 yearsThe Market Cap of Choksi Laboratories Ltd changed from ₹ 5.5 crore on March 2021 to ₹ 72.16 crore on March 2026 . This represents a CAGR of 53.58% over 6 years The revenue of Centenial Surgical Suture Ltd for the Jun '26 is ₹ 15.35 crore as compare to the Mar '26 revenue of ₹ 12.65 crore. This represent the growth of 21.34% The revenue of Choksi Laboratories Ltd for the Jun '26 is ₹ 12.08 crore as compare to the Mar '26 revenue of ₹ 12.88 crore. This represent the decline of -6.21% The ebitda of Centenial Surgical Suture Ltd for the Jun '26 is ₹ 2.19 crore as compare to the Mar '26 ebitda of ₹ 1 crore. This represent the growth of 119% The ebitda of Choksi Laboratories Ltd for the Jun '26 is ₹ 3.3 crore as compare to the Mar '26 ebitda of ₹ 3.71 crore. This represent the decline of -11.05% The net profit of Centenial Surgical Suture Ltd changed from ₹ 0.3 crore to ₹ 0.74 crore over 9 quarters. This represents a CAGR of 49.37% The net profit of Choksi Laboratories Ltd changed from ₹ 0.42 crore to ₹ 0.58 crore over 9 quarters. This represents a CAGR of 15.43% The Dividend Payout of Centenial Surgical Suture Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Choksi Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Centenial Surgical Suture Ltd

Incorporated in 1995, Centenial Surgical Suture Limited is engaged in the manufacture and sale of surgical sutures in India.
The company offers absorbable sutures that include natural and synthetic sutures and non absorbable sutures comprising needles for cardiovascular surgery, monofilament polyamide atraumatic needle suture combinations, monofilament stainless steel, and temporary pacemaker electrodes.
It also provides female urinary incontinency sets, titanium haemostatic clips for cardiovascular surgery, non absorbable. Company leverages the expertise and application knowledge of the global suture requirements for cardiovascular sutures in particular, to bring advanced atraumatic needle product development to the Indian Surgeons.
Continuous innovation in the areas of design, research and development of atraumatic needle, simulation and validation, testing and services, are the key value creation driver for the Company.

About Choksi Laboratories Ltd

Choksi Laboratories Limited, incorporated on 29 January, 1993 provides contract testing and analytical services.
CLL is a group of research laboratories and consulting offices, offering analysis, calibration, pollution control, research and consultancy services to a broad spectrum of industries.
The Company analyses, for its clients, or as a regulatory requirement pharmaceuticals, food and agricultural products, construction materials, chemicals, Calibration and environment Monitoring services. The Company currently has facilities for analysis of over 1000 products and materials, with more being added every day.
It provides calibration of production & quality control equipment with traceability to national / international standards.
This means that the equipment are precise and therefore reducing the probability of end-product defects / rejects.

FAQs for the comparison of Centenial Surgical Suture Ltd and Choksi Laboratories Ltd

Which company has a larger market capitalization, Centenial Surgical Suture Ltd or Choksi Laboratories Ltd?

Market cap of Centenial Surgical Suture Ltd is 24 Cr while Market cap of Choksi Laboratories Ltd is 144 Cr

What are the key factors driving the stock performance of Centenial Surgical Suture Ltd and Choksi Laboratories Ltd?

The stock performance of Centenial Surgical Suture Ltd and Choksi Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Centenial Surgical Suture Ltd and Choksi Laboratories Ltd?

As of October 25, 2026, the Centenial Surgical Suture Ltd stock price is INR ₹67.95. On the other hand, Choksi Laboratories Ltd stock price is INR ₹207.75.

How do dividend payouts of Centenial Surgical Suture Ltd and Choksi Laboratories Ltd compare?

To compare the dividend payouts of Centenial Surgical Suture Ltd and Choksi Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.